No Data
No Data
10-K: Annual report
8-K: Cyclacel Pharmaceuticals Reports FOURTH quarter financial results and provides business update
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
Cyclacel Pharmaceuticals Announces Leadership Change After $6.3M Share Purchase; Datuk Dr. Doris Wong Sing Ee Acquires 70% Stake And Becomes CEO; David Lazar Resigns As Interim CEO, Kiu Cu Seng Appointed CFO
Express News | Cyclacel Pharmaceuticals Inc - Datuk DR. Doris Wong Sing Ee Elected as CEO and Executive Director
Express News | Cyclacel Pharmaceuticals Inc - Spiro Rombotis Steps Down as CEO, David Lazar Appointed Interim CEO
JimyJimy : how can is no cements on here
JimyJimy : just you and me
JimyJimy : bought at 13 few shares